Latest Articles

Publication Date
Serum CA125, CA199, estradiol, FSH, IL-6, TNF-a in endometriosis after administration of Tripterygium wilfordii glycosides.

To evaluate the therapeutic effects of Tripterygium wilfordii glycosides on endometriosis (EMs) and their effects on serum sex hormone levels, tumour markers, and inflammatory factors (serum CA125, CA199, Estradiol, FSH, …

Published: Aug. 27, 2025, midnight
HOXC4 promotes proliferation of endometriotic stromal cells via the SLIT2-ROBO1 axis.

Current interventions for endometriosis mainly involve hormone therapies but have limited efficacy and unacceptable side effects due to the lack of selectivity to distinguish between endometriosis and endometrial tissues. Elucidating …

Published: Aug. 27, 2025, midnight
Nanotechnology strategies for endometrium health: Are we on the right track?

The endometrium is a vital mucosal tissue which undergoes cyclical regeneration, differentiation, and remodeling upon hormonal, cellular, and molecular signaling networks. Dysregulation of these processes can trigger a range of …

Published: Aug. 27, 2025, midnight
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Background/Objectives: Rarely, primary (PriCs) or metastatic (metECs) carcinomas occur in the episiotomy site. Methods: A systematic literature review of metECs was carried out. We reviewed the PRISMA guidelines and the …

Published: Aug. 27, 2025, midnight
New Perspectives on the Use of Resveratrol in the Treatment of Metabolic and Estrogen-Dependent Conditions Through Hormonal Modulation and Anti-Inflammatory Effects.

Estrogen-dependent conditions, such as endometriosis, adenomyosis, lipedema, polycystic ovary syndrome, and breast cancer, are intimately involved with hormonal changes related to estrogen and their receptors. These conditions can be expressed …

Published: Aug. 27, 2025, midnight
Real time alert setup for GTLB performance - Jobs Report & Daily Entry Point Trade Alerts - Newser

Real time alert setup for GTLB performance - Jobs Report & Daily Entry Point Trade Alerts Newser

Published: Aug. 26, 2025, 11:54 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com

Published: Aug. 26, 2025, 4:10 p.m.
Mum, 31, given terminal cancer diagnosis 'in shock' after two-year 'misdiagnosis' - Birmingham Live

Mum, 31, given terminal cancer diagnosis 'in shock' after two-year 'misdiagnosis' Birmingham Live

Published: Aug. 26, 2025, 9:21 a.m.
Mum discovers terminal cancer after 2-year misdiagnosis - upday News

Mum discovers terminal cancer after 2-year misdiagnosis upday News

Published: Aug. 26, 2025, 9:15 a.m.
Mum, 31, who thought she had endometriosis given terminal diagnosis - Liverpool Echo

Mum, 31, who thought she had endometriosis given terminal diagnosis Liverpool Echo

Published: Aug. 26, 2025, 8:50 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!